Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis
Overview
Affiliations
Systemic sclerosis (SSc) is a heterogenous systemic autoimmune disease of complex multi-organ manifestations with a disease-specific mortality of >50%. The patient journey is fraught with severe, diverse, and diffuse physical impairment, psychological burden, and diminishing health-related quality of life. SSc remains unfamiliar to many clinicians. Delayed/misdiagnosis, inadequate screening, and attention for common complications with potentially preventable disability/death contribute to patients feeling isolated and unsupported. We present actionable standards including screening, anticipatory guidance, and counseling in patient-centered SSc-care emphasizing psycho-social health as the central goal, whereas robust vigilance and efforts to improve biophysical health and survival are imperatives that support this goal.
Biomarkers in Systemic Sclerosis: An Overview.
Di Maggio G, Confalonieri P, Salton F, Trotta L, Ruggero L, Kodric M Curr Issues Mol Biol. 2023; 45(10):7775-7802.
PMID: 37886934 PMC: 10604992. DOI: 10.3390/cimb45100490.
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.
Muruganandam M, Ariza-Hutchinson A, Patel R, Sibbitt Jr W J Inflamm Res. 2023; 16:4633-4660.
PMID: 37868834 PMC: 10590076. DOI: 10.2147/JIR.S379815.